US20080177568A1 - Method and System for Pay-Per-Use Prescription Validation - Google Patents
Method and System for Pay-Per-Use Prescription Validation Download PDFInfo
- Publication number
- US20080177568A1 US20080177568A1 US11/626,660 US62666007A US2008177568A1 US 20080177568 A1 US20080177568 A1 US 20080177568A1 US 62666007 A US62666007 A US 62666007A US 2008177568 A1 US2008177568 A1 US 2008177568A1
- Authority
- US
- United States
- Prior art keywords
- information
- pharmacy
- validation
- validation system
- contents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H70/00—ICT specially adapted for the handling or processing of medical references
- G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/10—Office automation; Time management
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/04—Billing or invoicing
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
Definitions
- Improperly filled prescriptions represent a substantial risk of injury to customers at pharmacies.
- Filling prescriptions is a generally commoditized business where the objective is to maximize the number of prescriptions filled by each pharmacist per hour. It is inevitable that some prescriptions are filled with the incorrect drugs or medication.
- U.S. Pat. No. 6,771,369 concerns a system and method for pharmacy validation and inspection.
- the disclosed system provides a combination of a bar code reader and a spectroscopy system.
- a container of pills is provided with a label containing prescription information for a specific patient.
- the label is read by the system's bar code reader.
- the spectral response of the pills contained within the container is also resolved.
- a data analysis system then compares the information from the bar code reader with the spectral response information to ensure that the chemical content of the pills within the container matches the prescription.
- Such systems provide a way of confirming the accuracy of a filled prescription. Specifically, they insure that the contents of the container match the container's label. In this way, errors in prescriptions could be reduced.
- the present invention is directed to a business model for facilitating the deployment of prescription validation systems into pharmacies.
- pharmacies for little or no up-front cost to the pharmacy.
- the pharmacy is charged on a per use basis, i.e., charged every time a prescription is validated in the system or based on entirely or in part on the number of validations performed.
- the system vendor obtains payment on a subscription basis.
- up-front costs at the pharmacy are avoided.
- risks to a pharmacy concerning maintenance and slow productivity are avoided, or shifted onto the system owner, who is able to assess those risks.
- Payment per validation business model is similar to other business models used in the pharmacy industry. For example, currently, a process of “adjudication” is used whereby a pharmacist confirms the level of insurance of a given customer. Specifically, when a customer seeks to fill a prescription, the pharmacist will usually contact an insurance information clearing house, which provides the pharmacist with information concerning the level of coverage for that specific customer. In this way, the pharmacy can handle prescriptions from customers having different insurance and different coverage levels, while being assured that the insurance company will provide the expected level of reimbursement.
- FIG. 1 is a schematic diagram of a prescription validation system used in the present invention.
- FIG. 2 is a flow diagram illustrating a method for prescription validation and charges to a pharmacy.
- FIG. 1 shows a prescription validation system that is used in connection with the present invention, in one example.
- the validation system 100 is used to analyze the contents of a container, such as a pill container 50 .
- a container 50 typically representing a filled prescription, with a prescription specific label 52 on its outer surface, is placed within an analysis area 110 of the validation system 100 .
- both a spectrometer 114 and vision system 116 are oriented to view the contents of the container 50 , usually near its mouth 54 .
- the vision system 116 is used to check the shape, color, and symbols found on pills, for example, within the container 50 .
- the spectrometer 114 is used to collect the spectroscopic response of those same drugs, such as pills, within the container 50 .
- a label reader 112 reads the prescription information found on the label 52 .
- the label reader has an optical character recognition (OCR) system to decode the human-readable information encoded on the label 52 .
- OCR optical character recognition
- the label reader alternatively, or in addition, comprises a machine code reading component such as a bar code reader that reads a machine-readable, e.g., bar code, found on the label 52 .
- the prescription information from the label reader 112 , the spectroscopic information from the spectrometer 114 , and the pill shape, color, and symbol information from the vision system 116 are analyzed by the prescription validation system controller 120 .
- the controller 120 confirms whether the prescription has been properly filled. Specifically, the prescription information found on the label 52 is compared to the pill shape, color, and/or symbols that were determined by the vision system 116 and the composition of those pills as determined by the spectrometer 114 .
- the prescription validation system controller 120 connects to a pharmacy management system 130 .
- This contains the pharmacy's database for the drugs and/or drugs held by the pharmacy and/or the existing customers serviced by the pharmacy.
- the prescription validation system controller 120 confirms the prescription information on the label 52 is consistent with this back office system, for example, based on scheduled prescriptions to be filled at the pharmacy. That is, in one embodiment, the pharmacy management system comprises customer information and pending prescriptions to be filled. These prescription orders are then assigned to pharmacists at each validation system 100 .
- the pharmacy management system 130 updates the queue of prescriptions to be filled and confirms the validated prescriptions were to be filled.
- the prescription validation system controller 120 is also connected to a drug information center database 140 .
- connection is a data connection across a public network, such as the internet.
- the connection is supported by a dial-up connection or other direct point-to-point data communication.
- This drug information center includes databases of spectroscopic pill information and pill shape, color and symbol information.
- FIG. 2 shows the method of operation for the present invention.
- a prescription is received and entered into the billing/back office pharmacy management system 130 of the pharmacy.
- Most pharmacies have such a database system that stores previous prescriptions by a patient, the number of refills left on those prescriptions, insurance information for patients, billing information, and other account information.
- the system also controls pharmacy workflow in some examples so that prescriptions to be filled are distributed among the working pharmacists.
- the billing/back office pharmacy management system 130 contacts an insurance coverage clearing house. This step is often referred to as adjudication where the pharmacy determines whether the patient is covered, the insurance company, and the level of coverage to determine the level of reimbursement that the pharmacy will be receive from the customers' insurance.
- step 214 the drug is dispensed. Often, this filling is performed manually by pharmacist who puts a prescribed number of pills, for example, into the container 50 .
- step 216 pharmacist affixes the label 52 to the container 50 . Often this label 52 is printed directly by the billing/back office system 130 for the pharmacy.
- the steps of filling the container and/or printing and affixing the prescription label 52 to the container 50 are performed by an automated system. Especially in large pharmacies, there are machines that take entered prescription information and then automatically dispense the drugs into the containers 50 , including the required labels 52 .
- the container 50 is placed in the analysis area 110 (see FIG. 1 ).
- step 220 the validation system 100 acquires a spectroscopic data of the drug. Specifically the spectrometer 114 determines the spectral response of the pills contained in the container 50 .
- the validation system 100 also preferably acquires image information for the pills using the vision system 116 .
- this image recognition information includes the shape, color and any symbols contained on the pills.
- the validation system controller 120 searches for a match in an internal database 122 in step 224 . The system then determines whether or not there is a match for the pills based on the color, shape, symbols on the pills and/or the spectroscopic data on the pills in step 226 . If no match is found, then in step 228 , the validation system sends the spectroscopic, shape, color data, to the drug information center 140 .
- step 230 the drug information center 140 receives this spectroscopic and/or image recognition information from the validation system in step 230 . It searches in the center's database for a match. The drug center 140 then sends match information to the validation system 100 in step 232 or signals an error condition with no match being found.
- the center 140 signals for a recalibration of the validation system 100 , usually including a recalibration of the spectroscopy system 114 .
- the validation system 100 reads the label 52 and/or receives intended prescription information from the billing/back office system 130 . Specifically, the validation system 100 or management system 130 validates that a request for this prescription exists, that the drugs in the container match both the label 52 on the container 50 and the intended prescription in the back office system 130 .
- step 236 the validation system 100 notifies the pharmacist of a match or an invalid condition. That is, if there is a detected error in the data, the system signals that the particular prescription has not been properly filled.
- the drug center 140 also sends an update with the spectroscopic, shape, and color symbol data for the internal database 122 of the validation system controller 120 .
- the drug center 140 updates the internal database 122 , in one embodiment, of the validation system controller 120 based upon the requests that the validation sent in 228 . In this way, the validation system controller will signal a match if a similar drug is presented to the validation system in the future.
- the validation system controller 120 then updates its internal database 122 with the new spectroscopic, shape, color and symbol data from the drug center 140 .
- the validation system controller 120 notifies the drug information center 140 of the validation.
- the drug information center updates the pharmacy's billing information with this validation.
- the center 140 periodically sends a bill to the pharmacy. The charges are based on the number of validations that were performed over the billing period. In other examples the bill also includes rental or lease changes for the validation system 100 for the billing period.
- the pharmacy system notifies the center with accuracy information concerning the accuracy with which prescriptions are being filled at the pharmacy and any errors originating from the validation system 100 in step 246 .
- step 248 the drug center further updates its record information with this information from the local validation system at their pharmacy.
- the drug information center 140 periodically sends general updates for the internal database of the validation system. These internal updates are used, in one embodiment, to increase the probability of a match when the validation system 100 interrogates its internal database. For example, as the composition of pills, specifically pill coatings change, and/or with changes in color and introduction of instruction of new and generic pills, this information is continually sent by the drug information center 140 to update the internal database 122 of each validation system 100 at each pharmacy. Then, finally, in step 252 , the pharmacy validation system updates its internal database with the new data for its validation system.
Abstract
Description
- Improperly filled prescriptions represent a substantial risk of injury to customers at pharmacies. Filling prescriptions is a generally commoditized business where the objective is to maximize the number of prescriptions filled by each pharmacist per hour. It is inevitable that some prescriptions are filled with the incorrect drugs or medication.
- To address this problem, systems for the validation of prescriptions have been proposed. For example, U.S. Pat. No. 6,771,369 concerns a system and method for pharmacy validation and inspection. The disclosed system provides a combination of a bar code reader and a spectroscopy system. In operation, a container of pills is provided with a label containing prescription information for a specific patient. The label is read by the system's bar code reader. Contemporaneously, the spectral response of the pills contained within the container is also resolved. A data analysis system then compares the information from the bar code reader with the spectral response information to ensure that the chemical content of the pills within the container matches the prescription. Such systems provide a way of confirming the accuracy of a filled prescription. Specifically, they insure that the contents of the container match the container's label. In this way, errors in prescriptions could be reduced.
- The main impediment to the market penetration of prescription validation systems into the typical pharmacy is the cost of such systems. While there might be savings in terms of the pharmacy's liability insurance because of the decrease in the pharmacy's errors, the systems are comparatively expensive and represent an up-front cost to the typical pharmacy. Further, it is often unclear whether such systems will work accurately enough and at the speeds required in the pharmacy to justify investment. There are also risks to the pharmacy concerning costs of ownership including maintenance and equipment downtime.
- The present invention is directed to a business model for facilitating the deployment of prescription validation systems into pharmacies. Specifically, these systems are installed in pharmacies for little or no up-front cost to the pharmacy. Instead, the pharmacy is charged on a per use basis, i.e., charged every time a prescription is validated in the system or based on entirely or in part on the number of validations performed. In this way, the system vendor obtains payment on a subscription basis. At the same time, up-front costs at the pharmacy are avoided. Moreover, risks to a pharmacy concerning maintenance and slow productivity are avoided, or shifted onto the system owner, who is able to assess those risks.
- Payment per validation business model is similar to other business models used in the pharmacy industry. For example, currently, a process of “adjudication” is used whereby a pharmacist confirms the level of insurance of a given customer. Specifically, when a customer seeks to fill a prescription, the pharmacist will usually contact an insurance information clearing house, which provides the pharmacist with information concerning the level of coverage for that specific customer. In this way, the pharmacy can handle prescriptions from customers having different insurance and different coverage levels, while being assured that the insurance company will provide the expected level of reimbursement.
- The above and other features of the invention including various novel details of construction and combinations of parts, and other advantages, will now be more particularly described with reference to the accompanying drawings and pointed out in the claims. It will be understood that the particular method and device embodying the invention are shown by way of illustration and not as a limitation of the invention. The principles and features of this invention may be employed in various and numerous embodiments without departing from the scope of the invention.
- In the accompanying drawings, reference characters refer to the same parts throughout the different views. The drawings are not necessarily to scale; emphasis has instead been placed upon illustrating the principles of the invention. Of the drawings:
-
FIG. 1 is a schematic diagram of a prescription validation system used in the present invention; and -
FIG. 2 is a flow diagram illustrating a method for prescription validation and charges to a pharmacy. -
FIG. 1 shows a prescription validation system that is used in connection with the present invention, in one example. - The
validation system 100 is used to analyze the contents of a container, such as apill container 50. Specifically, in operation, acontainer 50, typically representing a filled prescription, with a prescriptionspecific label 52 on its outer surface, is placed within ananalysis area 110 of thevalidation system 100. - In one embodiment, both a
spectrometer 114 andvision system 116 are oriented to view the contents of thecontainer 50, usually near itsmouth 54. Thevision system 116 is used to check the shape, color, and symbols found on pills, for example, within thecontainer 50. Thespectrometer 114 is used to collect the spectroscopic response of those same drugs, such as pills, within thecontainer 50. - Simultaneously or contemporaneously, in one embodiment, a
label reader 112 reads the prescription information found on thelabel 52. In one example, the label reader has an optical character recognition (OCR) system to decode the human-readable information encoded on thelabel 52. In another example, the label reader alternatively, or in addition, comprises a machine code reading component such as a bar code reader that reads a machine-readable, e.g., bar code, found on thelabel 52. - The prescription information from the
label reader 112, the spectroscopic information from thespectrometer 114, and the pill shape, color, and symbol information from thevision system 116 are analyzed by the prescriptionvalidation system controller 120. Thecontroller 120 confirms whether the prescription has been properly filled. Specifically, the prescription information found on thelabel 52 is compared to the pill shape, color, and/or symbols that were determined by thevision system 116 and the composition of those pills as determined by thespectrometer 114. - According to the invention, the prescription
validation system controller 120 connects to apharmacy management system 130. This contains the pharmacy's database for the drugs and/or drugs held by the pharmacy and/or the existing customers serviced by the pharmacy. The prescriptionvalidation system controller 120 confirms the prescription information on thelabel 52 is consistent with this back office system, for example, based on scheduled prescriptions to be filled at the pharmacy. That is, in one embodiment, the pharmacy management system comprises customer information and pending prescriptions to be filled. These prescription orders are then assigned to pharmacists at eachvalidation system 100. As prescriptions are validated, thepharmacy management system 130 updates the queue of prescriptions to be filled and confirms the validated prescriptions were to be filled. - The prescription
validation system controller 120 is also connected to a druginformation center database 140. In one example, connection is a data connection across a public network, such as the internet. In other examples, the connection is supported by a dial-up connection or other direct point-to-point data communication. This drug information center includes databases of spectroscopic pill information and pill shape, color and symbol information. -
FIG. 2 shows the method of operation for the present invention. - As is common, in
step 210, a prescription is received and entered into the billing/back officepharmacy management system 130 of the pharmacy. Most pharmacies have such a database system that stores previous prescriptions by a patient, the number of refills left on those prescriptions, insurance information for patients, billing information, and other account information. The system also controls pharmacy workflow in some examples so that prescriptions to be filled are distributed among the working pharmacists. - Then, the billing/back office
pharmacy management system 130 contacts an insurance coverage clearing house. This step is often referred to as adjudication where the pharmacy determines whether the patient is covered, the insurance company, and the level of coverage to determine the level of reimbursement that the pharmacy will be receive from the customers' insurance. - Then in
step 214, the drug is dispensed. Often, this filling is performed manually by pharmacist who puts a prescribed number of pills, for example, into thecontainer 50. Instep 216, pharmacist affixes thelabel 52 to thecontainer 50. Often thislabel 52 is printed directly by the billing/back office system 130 for the pharmacy. - In other examples, the steps of filling the container and/or printing and affixing the
prescription label 52 to thecontainer 50 are performed by an automated system. Especially in large pharmacies, there are machines that take entered prescription information and then automatically dispense the drugs into thecontainers 50, including the required labels 52. Instep 218, thecontainer 50 is placed in the analysis area 110 (seeFIG. 1 ). - In
step 220, thevalidation system 100 acquires a spectroscopic data of the drug. Specifically thespectrometer 114 determines the spectral response of the pills contained in thecontainer 50. - In
step 222, thevalidation system 100 also preferably acquires image information for the pills using thevision system 116. Preferably this image recognition information includes the shape, color and any symbols contained on the pills. - Based on the spectroscopic and image information, the
validation system controller 120 searches for a match in aninternal database 122 instep 224. The system then determines whether or not there is a match for the pills based on the color, shape, symbols on the pills and/or the spectroscopic data on the pills instep 226. If no match is found, then instep 228, the validation system sends the spectroscopic, shape, color data, to thedrug information center 140. - In
step 230 thedrug information center 140 receives this spectroscopic and/or image recognition information from the validation system instep 230. It searches in the center's database for a match. Thedrug center 140 then sends match information to thevalidation system 100 instep 232 or signals an error condition with no match being found. - In the event of a non-match at the center's database, the
center 140 signals for a recalibration of thevalidation system 100, usually including a recalibration of thespectroscopy system 114. - Based upon the match information from the
drug center 140 or determined internally by reference to thedatabase 122 of thevalidation system controller 120, instep 224, thevalidation system 100 reads thelabel 52 and/or receives intended prescription information from the billing/back office system 130. Specifically, thevalidation system 100 ormanagement system 130 validates that a request for this prescription exists, that the drugs in the container match both thelabel 52 on thecontainer 50 and the intended prescription in theback office system 130. - Then in
step 236, thevalidation system 100 notifies the pharmacist of a match or an invalid condition. That is, if there is a detected error in the data, the system signals that the particular prescription has not been properly filled. - In
step 238, thedrug center 140 also sends an update with the spectroscopic, shape, and color symbol data for theinternal database 122 of thevalidation system controller 120. Specifically, thedrug center 140 updates theinternal database 122, in one embodiment, of thevalidation system controller 120 based upon the requests that the validation sent in 228. In this way, the validation system controller will signal a match if a similar drug is presented to the validation system in the future. Instep 240, thevalidation system controller 120 then updates itsinternal database 122 with the new spectroscopic, shape, color and symbol data from thedrug center 140. - According to the
step 242, thevalidation system controller 120 notifies thedrug information center 140 of the validation. Instep 224, the drug information center updates the pharmacy's billing information with this validation. In one embodiment, thecenter 140 periodically sends a bill to the pharmacy. The charges are based on the number of validations that were performed over the billing period. In other examples the bill also includes rental or lease changes for thevalidation system 100 for the billing period. - Often, the validations will cost only a few cents. Also, in one embodiment, the pharmacy system notifies the center with accuracy information concerning the accuracy with which prescriptions are being filled at the pharmacy and any errors originating from the
validation system 100 instep 246. - In
step 248, the drug center further updates its record information with this information from the local validation system at their pharmacy. - In
step 250, thedrug information center 140 periodically sends general updates for the internal database of the validation system. These internal updates are used, in one embodiment, to increase the probability of a match when thevalidation system 100 interrogates its internal database. For example, as the composition of pills, specifically pill coatings change, and/or with changes in color and introduction of instruction of new and generic pills, this information is continually sent by thedrug information center 140 to update theinternal database 122 of eachvalidation system 100 at each pharmacy. Then, finally, instep 252, the pharmacy validation system updates its internal database with the new data for its validation system. - While this invention has been particularly shown and described with references to preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details may be made therein without departing from the scope of the invention encompassed by the appended claims.
Claims (13)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/626,660 US20080177568A1 (en) | 2007-01-24 | 2007-01-24 | Method and System for Pay-Per-Use Prescription Validation |
US14/588,127 US10402543B2 (en) | 2007-01-24 | 2014-12-31 | Method and system for pay-per-use prescription validation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/626,660 US20080177568A1 (en) | 2007-01-24 | 2007-01-24 | Method and System for Pay-Per-Use Prescription Validation |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/588,127 Continuation US10402543B2 (en) | 2007-01-24 | 2014-12-31 | Method and system for pay-per-use prescription validation |
Publications (1)
Publication Number | Publication Date |
---|---|
US20080177568A1 true US20080177568A1 (en) | 2008-07-24 |
Family
ID=39642135
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/626,660 Abandoned US20080177568A1 (en) | 2007-01-24 | 2007-01-24 | Method and System for Pay-Per-Use Prescription Validation |
US14/588,127 Active 2029-09-11 US10402543B2 (en) | 2007-01-24 | 2014-12-31 | Method and system for pay-per-use prescription validation |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/588,127 Active 2029-09-11 US10402543B2 (en) | 2007-01-24 | 2014-12-31 | Method and system for pay-per-use prescription validation |
Country Status (1)
Country | Link |
---|---|
US (2) | US20080177568A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090127339A1 (en) * | 2007-11-18 | 2009-05-21 | Needham Bradford H | Medication recording device |
US20110303564A1 (en) * | 2010-06-14 | 2011-12-15 | Trutag Technologies, Inc. | System for producing a packaged item with an identifier |
WO2011159338A1 (en) * | 2010-06-14 | 2011-12-22 | Trutag Technologies, Inc. | System for verifying an item in a package |
WO2011159336A1 (en) * | 2010-06-14 | 2011-12-22 | Trutag Technologies, Inc. | System for verifying an item in a package using a database |
US20120203565A1 (en) * | 2011-02-07 | 2012-08-09 | Mckesson Specialty Arizona Inc. | Method and apparatus for providing improved patient medication adherence |
US9514131B1 (en) * | 2010-05-30 | 2016-12-06 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US10492991B2 (en) | 2010-05-30 | 2019-12-03 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4796181A (en) * | 1986-10-24 | 1989-01-03 | Wiedemer John D | Billing system for computer software |
US5925127A (en) * | 1997-04-09 | 1999-07-20 | Microsoft Corporation | Method and system for monitoring the use of rented software |
US20020091699A1 (en) * | 2000-11-02 | 2002-07-11 | Norton Phillip G. | Hosted asset information management system and method |
US20020137497A1 (en) * | 2001-03-21 | 2002-09-26 | Qwest Communications International Inc. | Calling name information caching |
US20030055683A1 (en) * | 2001-09-19 | 2003-03-20 | Gibson Jerry Tyrone | System and method for disseminating drug information |
US6771369B2 (en) * | 2002-03-12 | 2004-08-03 | Analytical Spectral Devices, Inc. | System and method for pharmacy validation and inspection |
US7028723B1 (en) * | 2003-11-03 | 2006-04-18 | Alouani Ali Tahar | Apparatus and method for automatic prescription verification |
WO2006074284A2 (en) * | 2005-01-06 | 2006-07-13 | Double Trump International Inc. | Software licensing method and system |
US20080162473A1 (en) * | 2006-12-29 | 2008-07-03 | Joachim Fitzer | Performing a Query In a Database |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8417539B2 (en) * | 2003-04-16 | 2013-04-09 | Optopo Inc. | Machine vision and spectroscopic pharmaceutical verification |
-
2007
- 2007-01-24 US US11/626,660 patent/US20080177568A1/en not_active Abandoned
-
2014
- 2014-12-31 US US14/588,127 patent/US10402543B2/en active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4796181A (en) * | 1986-10-24 | 1989-01-03 | Wiedemer John D | Billing system for computer software |
US5925127A (en) * | 1997-04-09 | 1999-07-20 | Microsoft Corporation | Method and system for monitoring the use of rented software |
US20020091699A1 (en) * | 2000-11-02 | 2002-07-11 | Norton Phillip G. | Hosted asset information management system and method |
US20020137497A1 (en) * | 2001-03-21 | 2002-09-26 | Qwest Communications International Inc. | Calling name information caching |
US20030055683A1 (en) * | 2001-09-19 | 2003-03-20 | Gibson Jerry Tyrone | System and method for disseminating drug information |
US6771369B2 (en) * | 2002-03-12 | 2004-08-03 | Analytical Spectral Devices, Inc. | System and method for pharmacy validation and inspection |
US7028723B1 (en) * | 2003-11-03 | 2006-04-18 | Alouani Ali Tahar | Apparatus and method for automatic prescription verification |
WO2006074284A2 (en) * | 2005-01-06 | 2006-07-13 | Double Trump International Inc. | Software licensing method and system |
US20080162473A1 (en) * | 2006-12-29 | 2008-07-03 | Joachim Fitzer | Performing a Query In a Database |
Non-Patent Citations (2)
Title |
---|
Cogdill, Process analytical technology case study, part III: Calibration monitoring and transfer, 2005, Volume 6, Number 2, Page E284-E297 * |
Jenny, Causes of Unsatisfactory Performance in Proficiency Testing, 2000, Clinical Chemistry 46:1, Page 89-99 * |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8740077B2 (en) | 2007-11-18 | 2014-06-03 | Intel-Ge Care Innovations Llc | Medication recording device |
US8448846B2 (en) * | 2007-11-18 | 2013-05-28 | Intel-Ge Care Innovations Llc | Medication recording device |
US9144399B2 (en) | 2007-11-18 | 2015-09-29 | Intel-Ge Care Innovations Llc | Medication recording device |
US20090127339A1 (en) * | 2007-11-18 | 2009-05-21 | Needham Bradford H | Medication recording device |
US10813836B2 (en) | 2010-05-30 | 2020-10-27 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US10492991B2 (en) | 2010-05-30 | 2019-12-03 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US10327987B1 (en) | 2010-05-30 | 2019-06-25 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US9514131B1 (en) * | 2010-05-30 | 2016-12-06 | Crisi Medical Systems, Inc. | Medication container encoding, verification, and identification |
US8881972B2 (en) | 2010-06-14 | 2014-11-11 | Trutag Technologies, Inc. | System for verifying an item in a package using a database |
CN106408309A (en) * | 2010-06-14 | 2017-02-15 | 特鲁塔格科技公司 | System for verifying an item in a package using a database |
US8596546B2 (en) | 2010-06-14 | 2013-12-03 | Trutag Technologies, Inc. | System for verifying an item in a package |
CN103189855A (en) * | 2010-06-14 | 2013-07-03 | 特鲁塔格科技公司 | System for verifying an item in a package using a database |
CN103154929A (en) * | 2010-06-14 | 2013-06-12 | 特鲁塔格科技公司 | System for producing a packaged item with an identifier |
US9033213B2 (en) * | 2010-06-14 | 2015-05-19 | Trutag Technologies, Inc. | System for producing a packaged item with an identifier |
KR20130057451A (en) * | 2010-06-14 | 2013-05-31 | 트루테그 테크놀로지스, 인코포레이티드 | System for producing a packaged item with an identifier |
US11166874B2 (en) * | 2010-06-14 | 2021-11-09 | Trutag Technologies, Inc. | System for producing a packaged item with an identifier |
CN106296226A (en) * | 2010-06-14 | 2017-01-04 | 特鲁塔格科技公司 | For producing the system of the packaging article with identifier |
JP2013530469A (en) * | 2010-06-14 | 2013-07-25 | トルタグ・テクノロジーズ・インコーポレーテッド | A system for verifying products in a package |
US10195109B2 (en) * | 2010-06-14 | 2019-02-05 | Trutag Technologies, Inc. | System for producing a packaged item with an identifier |
US10269022B2 (en) | 2010-06-14 | 2019-04-23 | Trutag Technologies, Inc. | System for verifying an item in a package using a database |
US20190167521A1 (en) * | 2010-06-14 | 2019-06-06 | Trutag Technologies, Inc. | System for producing a packaged item with an identifier |
WO2011159336A1 (en) * | 2010-06-14 | 2011-12-22 | Trutag Technologies, Inc. | System for verifying an item in a package using a database |
WO2011159338A1 (en) * | 2010-06-14 | 2011-12-22 | Trutag Technologies, Inc. | System for verifying an item in a package |
US20110303564A1 (en) * | 2010-06-14 | 2011-12-15 | Trutag Technologies, Inc. | System for producing a packaged item with an identifier |
US20120203565A1 (en) * | 2011-02-07 | 2012-08-09 | Mckesson Specialty Arizona Inc. | Method and apparatus for providing improved patient medication adherence |
Also Published As
Publication number | Publication date |
---|---|
US20150112714A1 (en) | 2015-04-23 |
US10402543B2 (en) | 2019-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10402543B2 (en) | Method and system for pay-per-use prescription validation | |
US8295977B2 (en) | Medicine dispenser | |
US8700209B2 (en) | Method and system for electronic assistance in dispensing pharmaceuticals | |
US7111780B2 (en) | Automated drug substitution, verification, and reporting system | |
US8849449B2 (en) | Method, system and apparatus for dispensing drugs | |
US8939365B1 (en) | Systems controlled by data bearing records for maintaining inventory data | |
AU702845B2 (en) | An automated medical prescription fulfillment system including bar code scanner | |
US6871783B2 (en) | Method of dispensing medical prescriptions | |
US8374965B2 (en) | System and method for verifying the contents of a filled, capped pharmaceutical prescription | |
US20040133705A1 (en) | Controller for dispensing products | |
US20090012820A1 (en) | Medication dose administration and inventory management | |
US20080128482A1 (en) | Drug dispense, identification, labeling and the system of inspection | |
CN1543628A (en) | Pos system having time-of-consumption management function of sales commodities | |
WO2013161694A1 (en) | Drug dispensing system | |
KR20200031549A (en) | A system for providing drug information using a block chain and method thereof | |
JP2012130779A (en) | Medicine dispensing device | |
CN1759359A (en) | Process delay monitoring system | |
US7860604B2 (en) | Method for controlling access to and segregating dispensed items | |
JP5472917B2 (en) | Transaction processing terminal device | |
CN1701328A (en) | Hand-held inventory tracking and automated order transmission system | |
US20090319293A1 (en) | Virtual inventory system and methods for covered entities | |
JP2002143273A (en) | Medicine supplementing system for medical institution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: AXSUN TECHNOLOGIES, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:KOTIDIS, PETROS;REEL/FRAME:019066/0222 Effective date: 20070322 |
|
AS | Assignment |
Owner name: VOLCANO CORPORATION, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AXSUN TECHNOLOGIES, INC.;REEL/FRAME:034059/0090 Effective date: 20140826 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION |
|
AS | Assignment |
Owner name: AXSUN TECHNOLOGIES, INC., MASSACHUSETTS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:VOLCANO CORPORATION;REEL/FRAME:036952/0260 Effective date: 20151005 Owner name: AXSUN TECHNOLOGIES LLC, MASSACHUSETTS Free format text: CHANGE OF NAME;ASSIGNOR:AXSUN TECHNOLOGIES, INC.;REEL/FRAME:037042/0660 Effective date: 20151016 |